Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	1. known allergy to pulmozyme 2. less than 18 years of age 3. grave condition with anticipated death within 48 hours; at the discretion of treating physician. 4. enrollment in another clinical trial receiving investigatory drugs	1. known allergy to pulmozyme 2. less than 18 years of age 3. grave condition with anticipated death within 48 hours; at the discretion of treating physician. 4. enrollment in another clinical trial receiving investigatory drugs
Nov. 16, 2021, 6:30 p.m.	usa	known allergy to pulmozyme less than 18 years of age grave condition with anticipated death within 48 hours; at the discretion of treating physician. enrollment in another clinical trial receiving investigatory drugs	known allergy to pulmozyme less than 18 years of age grave condition with anticipated death within 48 hours; at the discretion of treating physician. enrollment in another clinical trial receiving investigatory drugs
Oct. 26, 2020, 11:31 p.m.	usa	1. known allergy to pulmozyme 2. less than 18 years of age 3. grave condition with anticipated death within 48 hours; at the discretion of treating physician. 4. enrollment in another clinical trial receiving investigatory drugs	1. known allergy to pulmozyme 2. less than 18 years of age 3. grave condition with anticipated death within 48 hours; at the discretion of treating physician. 4. enrollment in another clinical trial receiving investigatory drugs